A randomized clinical trial of metformin in endometrial cancer

Editor’s choice: A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study Editorial: Rethinking metformin in advanced endometrial cancer: Scientific humility, translational challenges, and the urgency for equity Hosted by: Sean Dowdy, MD, FACS, FACOG, Associate Editor of Gynecologic Oncology Featuring: V.L. Bae-Jump, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Brian M. Slomovitz, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mount Sinai Medical Center, Miami Beach, FL Check out more content on the journal's homepage at

You can listen to A randomized clinical trial of metformin in endometrial cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

A randomized clinical trial of metformin in endometrial cancer is an episode from Gynecologic Oncology by Health Advance.

This episode is 17:26 long.

This episode was published on May 2, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Gynecologic Oncology when more episodes are available from the podcast feed.